These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33900546)

  • 1. A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.
    Kim YC; Hsueh HT; Shin MD; Berlinicke CA; Han H; Anders NM; Hemingway A; Leo KT; Chou RT; Kwon H; Appell MB; Rai U; Kolodziejski P; Eberhart C; Pitha I; Zack DJ; Hanes J; Ensign LM
    Drug Deliv Transl Res; 2022 Apr; 12(4):826-837. PubMed ID: 33900546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats.
    Hsueh HT; Chou RT; Rai U; Kolodziejski P; Liyanage W; Pejavar J; Mozzer A; Davison C; Appell MB; Kim YC; Leo KT; Kwon H; Sista M; Anders NM; Hemingway A; Rompicharla SVK; Pitha I; Zack DJ; Hanes J; Cummings MP; Ensign LM
    J Control Release; 2023 Oct; 362():371-380. PubMed ID: 37657693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
    Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
    Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.
    Hsueh HT; Kim YC; Pitha I; Shin MD; Berlinicke CA; Chou RT; Kimball E; Schaub J; Quillen S; Leo KT; Han H; Xiao A; Kim Y; Appell M; Rai U; Kwon H; Kolodziejski P; Ogunnaike L; Anders NM; Hemingway A; Jefferys JL; Date AA; Eberhart C; Johnson TV; Quigley HA; Zack DJ; Hanes J; Ensign LM
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34062883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury.
    Welsbie DS; Ziogas NK; Xu L; Kim BJ; Ge Y; Patel AK; Ryu J; Lehar M; Alexandris AS; Stewart N; Zack DJ; Koliatsos VE
    Mol Neurodegener; 2019 Nov; 14(1):44. PubMed ID: 31775817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.
    Mata D; Linn DM; Linn CL
    Neuropharmacology; 2015 Dec; 99():337-46. PubMed ID: 26239818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.
    Vigneswara V; Esmaeili M; Deer L; Berry M; Logan A; Ahmed Z
    Mol Cell Neurosci; 2015 Sep; 68():212-21. PubMed ID: 26260110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons.
    Welsbie DS; Mitchell KL; Jaskula-Ranga V; Sluch VM; Yang Z; Kim J; Buehler E; Patel A; Martin SE; Zhang PW; Ge Y; Duan Y; Fuller J; Kim BJ; Hamed E; Chamling X; Lei L; Fraser IDC; Ronai ZA; Berlinicke CA; Zack DJ
    Neuron; 2017 Jun; 94(6):1142-1154.e6. PubMed ID: 28641113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
    Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death.
    Welsbie DS; Yang Z; Ge Y; Mitchell KL; Zhou X; Martin SE; Berlinicke CA; Hackler L; Fuller J; Fu J; Cao LH; Han B; Auld D; Xue T; Hirai S; Germain L; Simard-Bisson C; Blouin R; Nguyen JV; Davis CH; Enke RA; Boye SL; Merbs SL; Marsh-Armstrong N; Hauswirth WW; DiAntonio A; Nickells RW; Inglese J; Hanes J; Yau KW; Quigley HA; Zack DJ
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4045-50. PubMed ID: 23431148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model.
    Ding Y; Chow SH; Chen J; Brun APL; Wu CM; Duff AP; Wang Y; Song J; Wang JH; Wong VHY; Zhao D; Nishimura T; Lee TH; Conn CE; Hsu HY; Bui BV; Liu GS; Shen HH
    Acta Biomater; 2021 May; 126():433-444. PubMed ID: 33774200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of retinal function by BDNF in a mouse model of glaucoma.
    Domenici L; Origlia N; Falsini B; Cerri E; Barloscio D; Fabiani C; Sansò M; Giovannini L
    PLoS One; 2014; 9(12):e115579. PubMed ID: 25536045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.
    Prokosch V; Schallenberg M; Thanos S
    PLoS One; 2013; 8(2):e49730. PubMed ID: 23468831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.
    Szabo E; Patko E; Vaczy A; Molitor D; Csutak A; Toth G; Reglodi D; Atlasz T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
    Shaw PX; Sang A; Wang Y; Ho D; Douglas C; Dia L; Goldberg JL
    Exp Eye Res; 2017 May; 158():33-42. PubMed ID: 27443501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems.
    Hakim A; Guido B; Narsineni L; Chen DW; Foldvari M
    Adv Drug Deliv Rev; 2023 May; 196():114781. PubMed ID: 36940751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
    Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
    Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.